Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
US7105530 | NOVARTIS | Pyrimidineamines as angiogenesis modulators |
Oct, 2023
(6 months from now) |
Market Authorisation Date: 19 October, 2009
Treatment: NA
Dosage: TABLET;ORAL
11
United States
3
Norway
2
Denmark
2
Hong Kong
2
Slovenia
2
Hungary
2
Germany
2
Portugal
2
Spain
2
European Union
1
Israel
1
South Africa
1
Austria
1
Mexico
1
Australia
1
Belgium
1
Brazil
1
Cyprus
1
Korea, Republic of
1
Poland
1
Czech Republic
1
China
1
Luxembourg
1
Japan
1
Canada
1
New Zealand
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic